April 17, 2018 / 4:12 PM / 8 days ago

BRIEF-DMS Signs Via Its DMS Biotech Unit Two Agreements For Lipofilling Solutions In Europe

April 17 (Reuters) - Diagnostic Medical Systems SA :

* ANNOUNCES UPDATES ON ITS DMS BIOTECH DIVISION

* SIGNATURE VIA DMS BIOTECH OF TWO NEW AGREEMENTS FOR LIPOFILLING SOLUTIONS IN EUROPE

* FILING OF NEW PATENT FOR PRODUCTION OF ADIPOSE TISSUE CELLS

* DMS BIOTECH SAYS HAS FINALIZED PROSPECTIVE STUDY ON EVALUATION OF STEMCIS’S TECHNOLOGY IN TREATMENT OF CANINE OSTEOARTHRITIS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below